CLINICAL_TRIALS
research
· 2026-03-30
Clinical Trial Update: The STOP-MED CTRCD Trial [Phase 4]
Summary
This clinical trial update reports that the STOP-MED CTRCD Phase 4 study is currently recruiting, focusing on cancer therapy–related cardiotoxicity and heart fa…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dinesh Thavendiranathan | Conditions: Heart Failure, Cardiotoxicity | Phase 4 | Status: RECRUITING